GHK-Cu vs Tretinoin
Well Studied vs FDA Approved
synergistic Researched · 95% Highly complementary combination for skin rejuvenation. GHK-Cu stimulates collagen synthesis, wound healing, and antioxidant enzyme production through copper-dependent pathways, while tretinoin drives collagen production via retinoic acid receptor activation. Together they target skin aging through distinct and additive mechanisms. Apply GHK-Cu serum and tretinoin at the same time in the evening routine, or use GHK-Cu in the morning.
Molecular Data
GHK-Cu Tretinoin
Weight 404.96 Da 300.44 Da
Half-life 0.5-2 hours 0.5-2 hours (topical, local skin metabolism)
Chain 3 amino acids —
Type Copper tripeptide Endogenous retinoid (vitamin A metabolite)
Key Benefits
GHK-Cu
01 Enhanced collagen production (70% increase in type I and III)
02 Improved skin elasticity
03 Reduced fine lines and wrinkles
04 Accelerated wound healing
05 Hair growth stimulation
06 Antioxidant protection
Tretinoin
01 Reduces fine lines and wrinkles with consistent long-term use (strongest evidence of any topical)
02 Stimulates new collagen synthesis (procollagen I and III) in photoaged skin
03 Accelerates epidermal cell turnover, improving skin texture and smoothness
04 Reduces mottled hyperpigmentation and evens skin tone
05 FDA-approved treatment for acne vulgaris with over 50 years of clinical use
06 Treats and prevents comedonal and inflammatory acne by normalizing follicular keratinization
07 Enhances penetration and efficacy of other active skincare ingredients
Dosing Protocols
GHK-Cu
0.5-2% topical or 1-3mg injectable / 1-2x daily
Systemic anti-aging 1-2mg 1x daily
Enhanced regeneration 2-3mg 1-2x daily
Tretinoin
0.025-0.05% cream or gel, applied nightly / Once daily (evening)
Side Effects
GHK-Cu
Mild skin irritation initially (usually resolves)
Increased photosensitivity
Tretinoin
Peeling and flaking (retinoid dermatitis), especially in the first 2-6 weeks
Erythema (redness) and skin irritation at the application site
Dryness and tightness of the skin
Increased photosensitivity (heightened susceptibility to sunburn)
Initial acne purging (transient worsening of breakouts in weeks 2-6)
Contraindications
Known copper sensitivity or Wilson's disease
Active skin infections at application site
Pregnancy or breastfeeding (injectable)
Pregnancy and women planning to become pregnant (tretinoin is a known teratogen; oral retinoids cause severe birth defects, and while topical absorption is minimal, it is contraindicated as a precaution)
Breastfeeding (safety not established for topical tretinoin during lactation)
Known hypersensitivity to tretinoin, other retinoids, or any formulation excipients
Active eczema, rosacea, or severely compromised skin barrier at the application site
Concurrent use of other strong topical irritants without medical supervision (e.g., benzoyl peroxide at high concentrations on the same area at the same time)
Research Evidence
GHK-Cu Tretinoin
Status Well Studied FDA Approved
References 5 studies 5 studies
Latest July 2025 —
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.